[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100445484":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":37,"responsibleParty":58,"collaborators":60,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":74,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":18,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":89,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"KK Women's and Children's Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Wearable Care Group","EXPERIMENTAL","This group will receive both a continous glucose monitoring sensor and an exercise tracker to be worn for at least 2 weeks at each study visit timepoint.",[13],"Device: Wearable Care Group",{"label":15,"type":16,"description":17,"interventionNames":18},"Scheduled Care Group","NO_INTERVENTION","This group will receive standard medical care with dietary and nutritional advice alone.",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"DEVICE","Continous glucose monitoring sensor: Study participants wear the sensor on the back of either right or left upper arm for up to 14 days. Glucose levels will be recorded from the interstitial fluid every 15 minutes using intermittent\u002F flash glucose scanning.\n\nExercise tracker: A FitBit watch will be given to the participants for use to track physical activity levels.",[9],[25],{"name":26,"affiliation":5,"role":27},"Kok Hian Tan, MD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":18,"email":32},"CONTACT","65 6394 1099","tan.kok.hian@singhealth.com.sg",{"name":34,"role":30,"phone":35,"phoneExt":18,"email":36},"Phaik Ling Quah, PhD","97732543","quah.phaik.ling@kkh.com.sg",[38],{"facility":5,"status":39,"city":40,"state":18,"zip":41,"country":40,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Singapore","229899","SG",{"type":44,"coordinates":45},"Point",[46,47],103.85007,1.28967,{"lat":47,"lon":46},[50,52,53,54,56],{"name":51,"role":30,"phone":35,"phoneExt":18,"email":32},"KK WAC Hospital, MD",{"name":34,"role":30,"phone":35,"phoneExt":18,"email":36},{"name":26,"role":27,"phone":18,"phoneExt":18,"email":18},{"name":34,"role":55,"phone":18,"phoneExt":18,"email":18},"SUB_INVESTIGATOR",{"name":57,"role":55,"phone":18,"phoneExt":18,"email":18},"Wai Kheong,Ryan Lee, MD",{"type":59,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR",[61,64],{"name":62,"class":63},"Duke-NUS Graduate Medical School","OTHER",{"name":65,"class":63},"Institute for Human Development and Potential (IHDP), Singapore","100445484","integrated-hyperglycaemia-incentivised-postnatal-surveillance-study-i-hips-100445484",false,"NCT05081037","Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)","Lifestyle Interventions to Prevent Postpartum Type II Diabetes Mellitus in Asian Women With a History of Gestational Diabetes Mellitus","I-HIPS","Inclusion Criteria:\n\n1. Women diagnosed antenatally with GDM by IADPSG criteria (15)\n2. Normal 6 weeks post-natal OGTT\n3. BMI range from 20-40\n4. Physically fit to participate in moderate intensity walking\n\nExclusion Criteria:\n\n1. Women with serious skin conditions (e.g. eczema) that precludes wearing the sensor for 14 days\n2. Women who have any other serious chronic disease such as chronic kidney disease and heart disease",true,"FEMALE","21 Years","45 Years",{"count":79,"type":80},300,"ESTIMATED","INTERVENTIONAL",[83],"NA","This study aims to test the following hypotheses in a randomized controlled trial of post-partum women with a history of gestational diabetes mellitus (GDM) that will be followed up for up to 4 years:\n\n1. Post-partum pregnancy is ideal for behavioural modification and adopting a healthy lifestyle. Using the continous glucose monitoring (CGM) sensor and an exercise tracker will promote self-motivation and awareness by positive reinforcement and behavioural changes to improve diet, control body weight and increase physical activity in this group of post-partum women who are at high risk for developing Type II Diabetes.\n2. The use of the continous glycose monitoring (CGM) sensor and exercise tracker will motivate women to modify their dietary food intake and physical activity over time, reducing their cardiovascular risk factors for developing metabolic syndrome by lowering their baseline blood pressure, BMI, reducing their waist circumference and body fat mass, glycaemic levels and fasting lipids within the targeted healthy range.\n3. There will be an increase in the quality adjusted life years (QALYs) gained based on improvements in HbA1C and other proximal outcomes at the end of the trial.",[86,87,88],"Gestational Diabetes","Glucose Metabolism Disorders","Metabolic Disease",[90,91,92],"gestational diabetes","post-partum intervention","Body composition","2025-04-15",{"date":95,"type":96},"2025-04-17","ACTUAL",{"date":98,"type":96},"2021-09-06",{"date":100,"type":80},"2026-05-26",{"name":5,"class":6},1]